Alpine Immune Sciences Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2024 to a ratio of 317.53, this represents a new company high. This is a clear indication for improving liquidity at Alpine Immune Sciences Inc 's clients. Average receivable collection period, for the Alpine Immune Sciences Inc in Mar 31 2024 quarter, has decreased to 1 days, compared to 2 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 5 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 47, from overall ranking in the fourth quarter 2023 at 2999.

What is Receivable Turnover Ratio?
What is Alpine Immune Sciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALPN Receivables Turnover Ratio	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Receivable Change	-93.71 %	-57.4 %	-42.67 %	-78.44 %	406.06 %
Y / Y Revenue Change	-25.09 %	1011.42 %	20.03 %	62.38 %	-31.12 %
Receivable Turnover Ratio (TTM)	317.53	176.01	78.82	67.49	37.44
ALPN's Total Ranking	# 47	# 2999	# 2999	# 47	# 2438
Accounts Receivable average collection period days	1	2	5	5	10
Seq. Receivable Change	-74.85 %	-23.74 %	-22.89 %	-57.49 %	70.41 %
Seq. Revenue Change	-77.21 %	207.21 %	16.87 %	-8.46 %	238.15 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 1
Healthcare Sector	# 6
Overall Market	# 47

Receivable Turnover Ratio Statistics
High	Average	Low
317.53	62.33	1.33
(Mar 31 2024)		(Dec 31 2021)

ALPN Company Profile • Back to ALPN Efficiency Comparisons • Compare ALPN Receivables Turnover Ratio to its Competitors

Financial Statements
Alpine Immune Sciences Inc 's Accounts Receivable	$ 0 Millions	Visit ALPN's Balance sheet
Alpine Immune Sciences Inc 's Sales TTM	$ 57 Millions	Visit ALPN's Income Statement
Sources of ALPN's Revenues		Visit ALPN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ALPN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ALPN's Growth Rates	ALPN's Roa	ALPN's Inventory Turnover Ratio	ALPN's Dividend Comparisons
ALPN's Profitability Ratios	ALPN's Roi	ALPN's Asset Turnover Ratio	ALPN's Dividend Growth
ALPN's Valuation Ratios	ALPN's Roe	ALPN's Financial Strength Ratios	ALPN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2024	Receivable at quarter ending Mar 31 2024
Provectus Biopharmaceuticals Inc	792.43	$ 0.591 Millions	$ 0.001 Millions
Warby Parker Inc	575.32	$ 696.715 Millions	$ 1.211 Millions
Relay Therapeutics Inc	488.96	$ 35.327 Millions	$ 0.072 Millions
Nakamoto Inc	438.99	$ 0.829 Millions	$ 0.002 Millions
Iqvia Holdings Inc	374.39	$ 15,069.000 Millions	$ 40.250 Millions
Alpine Immune Sciences Inc	317.53	$ 56.521 Millions	$ 0.178 Millions

Date modified: 2026-08-29T17:31:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.